Fetal Retinoid Syndrome
Symptoms, Doctors, Treatments, Advances & More

Fetal Retinoid Syndrome Overview

Save information for later
Sign Up

Learn About Fetal Retinoid Syndrome

What is the definition of Fetal Retinoid Syndrome?
Fetal retinoid syndrome is a characteristic pattern of physical birth defects in a baby that has been exposed to retinoids during pregnancy. The best-known retinoid is isotretinoin (Accutane), a drug used to treat severe cystic acne. Babies exposed to retinoids during pregnancy may have a wide variety of symptoms. Some may have no symptoms at all, others may have only intellectual and learning problems, while others will have very severe symptoms. Birth defects associated with retinoid exposure include: • Growth delay • Excess fluid around the brain (hydrocephalus) • Abnormally small head size (microcephaly) • Intellectual and learning disabilities • Ear and eye abnormalities • A split in the roof of the mouth (cleft palate) and other facial differences • Heart defects. It is thought that 20-35% of fetuses exposed to retinoids during pregnancy will develop some of these birth defects. Retinoids can cause these birth defects in the early weeks of pregnancy, even before a woman knows that she is pregnant. Some of the birth defects associated with Fetal retinoid syndrome may be diagnosed by ultrasound during pregnancy. Currently, public health programs exist to help reduce the chance that a woman will use retinoids if she is considering getting pregnant.
What are the alternative names for Fetal Retinoid Syndrome?
  • Fetal retinoid syndrome
  • Accutane fetal effects of
  • Accutane-exposed pregnancies
  • Acutane embryopathy
  • Isotretinoin (RoAccutane) embryopathy
  • Isotretinoin embryopathy
  • Isotretinoin fetal effects of
  • Isotretinoin teratogen syndrome
Who are the top Fetal Retinoid Syndrome Local Doctors?
Elite in Fetal Retinoid Syndrome
Elite in Fetal Retinoid Syndrome
Referral may be required
Jerusalem, JM, IL 

Abraham Fainsod practices practicing medicine in Jerusalem, Israel. Mr. Fainsod is rated as an Elite expert by MediFind in the treatment of Fetal Retinoid Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Fetal Retinoid Syndrome, Fetal Alcohol Syndrome (FAS), Campomelic Dysplasia, and Campomelia Cumming Type.

Distinguished in Fetal Retinoid Syndrome
Distinguished in Fetal Retinoid Syndrome
Referral required
Before you request

Yale New Haven Hospital

20 York St, 
New Haven, CT 
203-688-2259
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christopher Bunick is a Dermatologist practicing medicine in New Haven, Connecticut. Dr. Bunick is rated as a Distinguished provider by MediFind in the treatment of Fetal Retinoid Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Lamellar Ichthyosis, Nonbullous Congenital Ichthyosiform Erythroderma, Acne, and Atopic Dermatitis. Dr. Bunick is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Fetal Retinoid Syndrome
Advanced in Fetal Retinoid Syndrome
Referral may be required
Before you request

Peachtree Dermatology Associates

371 E. Paces Ferry Road, Suite 900, 
Atlanta, GA 
404-355-1919
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Laura Ragmanauskaite is a Dermatologist practicing medicine in Atlanta, Georgia. Dr. Ragmanauskaite is rated as an Advanced provider by MediFind in the treatment of Fetal Retinoid Syndrome. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Fetal Retinoid Syndrome, Acne, and DRESS Syndrome. Dr. Ragmanauskaite is board certified in American Board Of Dermatology. Dr. Ragmanauskaite is currently accepting new patients.

View All Doctors
What are the latest Fetal Retinoid Syndrome Clinical Trials?
The Impact of COVID-19 on Maternal and Neonatal Outcomes
The Impact of COVID-19 on Maternal and Neonatal Outcomes
Enrollment Status: Recruiting
Publish Date: May 11, 2026
Intervention Type: Biological

Summary: The novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldwide pandemic. There is still much that is unknown regarding the virus, especially its effects on pregnancy, the fetus, and the neonate. This study seeks to evaluate adverse pregnancy and neonatal outcomes related to COVID-19 infection. The FDA has authorized emergency use authorization for the SARS-CoV-2 messenger ribonucle...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Cancer of the Pancreas Screening-5 CAPS5)Study
The Cancer of the Pancreas Screening-5 CAPS5)Study
Who is this study for: Patients with hereditary pancreatitis or
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Drug, Diagnostic test
Study Phase: Phase 3

Summary: Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center